G Medical Innovations logo

G Medical Innovations(OTC) GMVDF

Market Cap$26.00KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2018)-100%
5 Year-100%
1 Year+0%
1 Month+0%
$0.00
+0.00%
+0.00Today
G Medical Innovations last closing stock price
MetricPriceDate
Last closeUSD 0.002026-10-15
G Medical Innovations stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002026-10-08
1 month+0%USD 0.002026-09-14
3 month+0%USD 0.002026-07-06
Year to date-50%USD 0.002025-12-31
1 year+0%USD 0.002025-10-14
3 year-99.68%USD 0.032023-10-16
5 year-100%USD 79.802021-10-15
Since inception-100%USD 43.752018-01-31

G Medical Innovations Financials at a Glance

Market Cap

$26.00KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$10.17M

Net Income (TTM)

-$35.42M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

611.42 (High)

Price

$0.00

Volume

303

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.03

Estimated Earnings Date

Sep 2, 2026

GMVDF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About G Medical Innovations

G Medical Innovations Holdings Ltd is an emerging healthcare enterprise focused on advanced mobile health and remote medical solutions. The company operates primarily in the United States, China, and Israel, offering innovative products designed to enhance patient care and monitoring.

Products and Services
  • Prizma: A medical device for measuring vital signs with electronic medical record functionality
  • Extended Holter Patch System: A multi-channel biosensor for continuous ECG data recording
  • Wireless Vital Signs Monitoring System: Aiming for real-time tracking of physiological parameters
Growth Outlook
  • Expansion into new markets in the U.S. and China is underway
  • Development of innovative products aligns with increasing demand for telehealth solutions
  • Strategic partnerships may enhance distribution and market reach
Financial Highlights
  • Recent quarterly revenue of $2.224 million shows growth potential
  • Trailing twelve months (TTM) gross profit margin at 17.74% indicates operational efficiency
  • Cash and cash equivalents increased to $1.509 million in Q2 2022
G Medical Innovations Holdings Ltd is positioned in the medical devices industry, focusing on mobile health solutions that cater to the evolving needs of healthcare providers and patients. The company's flagship products, such as Prizma and the Extended Holter Patch System, are designed to provide accurate and timely health data, which is increasingly vital in today's healthcare landscape. The growth outlook for G Medical Innovations appears promising, with plans for market expansion and product development that align with the rising demand for telehealth services. Recent financial performance indicates a revenue increase, suggesting that the company is on a path toward improved operational efficiency and market presence. Investors may find G Medical Innovations Holdings Ltd an intriguing opportunity, given its innovative approach to healthcare technology and the potential for future growth in a rapidly evolving industry.
AI Generated • Oct 7, 2026

Industry

Healthcare Providers and Services

Sector

Health Care

CEO

Yacov Geva, PhD

Website

www.gmedinnovations.com

Headquarters

Rehovot, TA 7670105, IL

GMVDF Financials

Key Financial Metrics (TTM)

Gross Margin

17.74%

Operating Margin

-500.29%

Net Income Margin

-557.22%

Return on Equity

368.04%

Return on Capital

N/A

Return on Assets

-510.45%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$26.00KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

259.92M

Volume

303

Avg. Volume

715.662

Financials (TTM)

Gross Profit

-$2.22M

Operating Income

-$39.72M

EBITDA

-$24.42M

Operating Cash Flow

-$30.24M

Capital Expenditure

-$2.64M

Free Cash Flow

-$32.88M

Cash & ST Invst.

$295.00K

Total Debt

$2.09M

G Medical Innovations Performance Analysis

G Medical Innovations annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-12-31USD 4,961,000N/A
20222022-12-31USD 4,420,000-10.9%
G Medical Innovations sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22021-06-30N/A
Q42021-12-31N/A
Q22022-06-30N/A
Q42022-12-31N/A
G Medical Innovations annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-12-31USD -1,592.01N/A
20222022-12-31USD -34.17-97.9%
G Medical Innovations sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22021-06-30N/A
Q42021-12-31N/A
Q22022-06-30N/A
Q42022-12-31N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2022YOY CHG

Revenue

$2.22M

+10.6%

Gross Profit

-$4.92M

-838.4%

Gross Margin

-2.21%

N/A

Market Cap

$26.00KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$309.52

N/A

Employees

84

N/A

Net Income

-$13.02M

-165.7%

EBITDA

-$8.25M

-142.7%

Quarterly Fundamentals

Name
Q2 2022YOY CHG

Total Cash

$295.00K

-67.5%

Total Debt

$2.09M

-26.7%

Accounts Receivable

$944.00K

-26.7%

Inventory

$292.00K

+33.9%

Long Term Debt

$283.00K

-43.2%

Short Term Debt

$1.81M

-23.2%

Return on Assets

-5.10%

N/A

Return on Invested Capital

5.16%

N/A

Free Cash Flow

-$18.22M

-573.3%

Operating Cash Flow

-$16.43M

-557.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MCRTMicroart Inc.
$0.00+0.00%
CBDXCurative Biosciences, Inc.
$0.00+0.00%
AZFLAmazonas Florestal, Ltd
$0.00+0.00%
GNLKQGeneLink, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
SPCXSpace Exploration Technologies
$159.31+7.80%
NFLXNetflix
$65.04-5.31%
NVDANvidia
$221.97+2.54%
TAT&T
$21.91-6.45%

Questions About GMVDF

What is the current price of G Medical Innovations?

G Medical Innovations is trading at $0.00 per share.

What is the 52-week range for G Medical Innovations?

Over the past 52 weeks, G Medical Innovations has traded between $0.00 and $0.03.

How much debt does G Medical Innovations have?

As of the most recent reporting period, G Medical Innovations reported total debt of $2.09M.

How much cash does G Medical Innovations have on hand?

G Medical Innovations reported $437.00K in cash and cash equivalents in its most recent financial results.

What is G Medical Innovations’s dividend yield?

G Medical Innovations does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services